Sign In
Buy AVDL
$21.64
+0 (+0%)
At Close: May 08, 2026
Avadel Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 10th
12:00pm, Monday, 27'th Jul 2020
DUBLIN, Ireland, July 27, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, August 10,
Avadel Pharmaceuticals (NASDAQ:AVDL) Upgraded to Hold at BidaskClub
02:16am, Monday, 20'th Jul 2020
Avadel Pharmaceuticals (NASDAQ:AVDL) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Saturday, BidAskClub reports. A number of oth
Zacks: Brokerages Anticipate Avadel Pharmaceuticals PLC (NASDAQ:AVDL) Will Post Earnings of -$0.16 Per Share
03:18pm, Thursday, 16'th Jul 2020
Equities research analysts expect Avadel Pharmaceuticals PLC (NASDAQ:AVDL) to post earnings of ($0.16) per share for the current quarter, according to Zacks Investment Research. Four analysts have mad
Assessing An Investment In Avadel Pharmaceuticals
12:51pm, Thursday, 16'th Jul 2020
Today, we take an in-depth look at Avadel Pharmaceuticals which recently sold off its existing product portfolio.
Equillium COVID-19 Data, And Other News: The Good, Bad And Ugly Of Biopharma
11:49am, Wednesday, 15'th Jul 2020
Equillium reports positive data for COVID-19 drug trial. CytoDyn's BLA filing is rejected.
Clinical study to enroll 250 patients from sites that participated in the REST-ON studyStudy to examine the long-term safety and maintenance of efficacy in patients, and.
Jazz Pharmaceuticals: Buy, Sell, Or Hold (NASDAQ:JAZZ)
05:00pm, Thursday, 09'th Jul 2020
Jazz Pharmaceuticals plc is trading at 9x revised 2020E Adj. EPS after dropping ~30% since mid-January.
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
10:16am, Wednesday, 08'th Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avadel Pharmaceuticals
Avadel Pharmaceuticals (AVDL) Gets a Buy Rating from LifeSci Capital - Markets
12:42pm, Sunday, 05'th Jul 2020
LifeSci Capital analyst David Sherman maintained a Buy rating on Avadel Pharmaceuticals (AVDL – Research Report) on July 1 and
Bearish: Analysts Just Cut Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Revenue and EPS estimates
11:05am, Friday, 03'rd Jul 2020
Market forces rained on the parade of Avadel Pharmaceuticals plc (NASDAQ:AVDL) shareholders today, when the analysts...
H.C. Wainwright Thinks Zynerba Pharmaceuticals' Stock is Going to Recover - Markets
12:15pm, Wednesday, 01'st Jul 2020
H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Zynerba Pharmaceuticals (ZYNE – Research Report) today and set a
Avadel Announces Sale of Hospital Sterile Injectable Drug Portfolio for $42.0 Million
12:00pm, Wednesday, 01'st Jul 2020
Avadel Pharmaceuticals plc (AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in pat
Analysts Are Bullish on These Healthcare Stocks: Sol-Gel Technologies (SLGL), Seattle Genetics (SGEN) - Markets
10:13am, Tuesday, 30'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sol-Gel Technologies
Pot Slump Creates Distressed Opportunities: Cannabis Weekly - BNN Bloomberg
03:02pm, Sunday, 28'th Jun 2020
Cannabis stocks have lost about a quarter of their value in the first half of 2020, compounding a 50% drop in 2019.
Pot Slump Creates Distressed Opportunities: Cannabis Weekly
03:00pm, Sunday, 28'th Jun 2020
(Bloomberg) — Cannabis stocks have lost about a quarter of their value in the first half of 2020, compounding a 50% drop in 2019.The upside for investors? There’s never been a better ti…
